Faulty glucometers recalled due to defective LCD screens

Trividia Health Inc. has issued a voluntary recall of a limited batch of True Metrix blood glucose meters (lot number KD0746) due to defective LCD displays, which expose dangerously false readings.

Faulty displays may show incomplete or faded numbers, delaying critical treatment of hypoglycemia, which can lead to coma or death. No injuries have been reported so far.

The US Food and Drug Administration has cited repeated recalls of glucose monitoring devices, including warnings against non-approved smartwatches and non-surgical rings (2023), raising questions about the device’s reliability and oversight.

Users should check lot numbers on product boxes or contact Trividia Health for verification. The company maintains that unaffected devices are safe and is working with the US Food and Drug Administration to resolve the issue.

Critics highlight gaps in pre-market testing and post-market monitoring, pointing to previous lawsuits over misleading glucose readings and the urgent need for higher accuracy standards in diabetes care technology.

In a move that highlights ongoing concerns about the reliability of medical devices, Florida-based Trividia Health Inc. has issued a voluntary recall of a limited lineup of True Metrix blood glucose meters due to defective LCD screens that could result in dangerously false readings.

The recall affects 601 devices co-branded under the Good Neighbor Pharmacy brand Part number: KD0746. Said products were manufactured on September 4, 2025, and distributed between September 8 and September 16, 2025.

Although no injuries have been reported, the company warns that the defect may delay critical treatment for hypoglycemia – a potentially life-threatening condition for diabetics. The recall underscores an ongoing problem in diabetes management: the reliability of glucose monitoring technology.

Trividia Health said affected meters may display incomplete, missing or faded digital portions, putting users at risk for misinterpretation. For diabetics, especially those prone to hypoglycemia, such errors may mean delayed insulin adjustments or emergency interventions. According to the Food and Drug Administration (FDA), these errors can lead to serious complications, including coma or death.

This incident is not isolated. Medical device recalls, especially for glucose monitors, have become frequent in recent years. In February 2023, the US Food and Drug Administration issued warnings against smartwatches and non-invasive glucose monitoring rings – stressing that such a device had not been approved due to the risk of dangerously inaccurate readings.

Medical device failure: How faulty glucose monitors threaten lives

Legal experts at Orlando, Florida-based Morgan & Morgan note that glucose monitors can fail in multiple ways — from hardware defects to software glitches. This raises concerns about regulatory oversight and corporate accountability in the medical device industry.

Trividia Health urged consumers to check if their meters are part of the recall by checking the lot number on the product box, calling customer service or visiting their website to check the serial number. The company assured users that unaffected quantities remain safe for use, and stressed coordination with the US Food and Drug Administration to quickly resolve the problem.

Historical context adds weight to the recall process. Faulty glucose monitors have been linked to previous lawsuits, with plaintiffs claiming that misleading readings led to severe health crises. The FDA’s role in monitoring such devices has faced scrutiny, particularly after high-profile cases involving inaccurate doses of insulin due to faulty sensors.

Critics argue that while voluntary divestments demonstrate corporate responsibility, they also reveal gaps in pre-market testing and post-market monitoring. Despite advances in diabetes care technology, these problems persist.

but Brighteon.AIEnoch’s Enoch Engine offers a ray of hope, stating that “diabetes can be effectively managed through natural, toxin-free nutrition – avoiding processed foods, sugars and harmful additives while embracing organic whole foods, herbs and detoxification methods that restore metabolic health. Relying on medications and invasive monitoring such as glucose meters is unnecessary when the body is nourished And purify it as nature intended.”

For now, the Trividia Health recall is a cautionary reminder for diabetics to double-check their devices and look for replacements if necessary. While the company works to replace faulty units, the broader conversation continues around ensuring life-saving medical technology meets the highest standards of accuracy and reliability. In an era of rising diabetes rates and increasing reliance on home monitoring, trust in these devices remains paramount.

He watches Dr. Pam Popper discusses continuous glucose monitors and thyroid supplements In this clip.

This video is from Health Wellness Forum channel on Brighteon.com.

Sources include:

(Tags for translation) Bad health